FDA.reportPublic FDA data

Application 205582

Type
NDA
Sponsor
SUN PHARMA GLOBAL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DECITABINEDECITABINEPOWDER;INTRAVENOUS50MG/VIALYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N205582-001DECITABINEDECITABINE50MG/VIALPOWDER / INTRAVENOUSRLD2014-01-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N205582-001DECITABINE50MG/VIALPOWDER / INTRAVENOUSRLD, RS2014-01-28f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N205582-001DECITABINE50MG/VIALPOWDER / INTRAVENOUSRLD, RS2014-01-28e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N205582-001DECITABINE50MG/VIALPOWDER / INTRAVENOUSRLD, RS2014-01-28cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N205582-001DECITABINE50MG/VIALPOWDER / INTRAVENOUSRLD2014-01-28a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
decitabineDECITABINESun Pharmaceutical Industries, Inc.c155d6ba-9a16-406c-919e-65a149689ab92020-07-23Warnings, Adverse reactionsExact identifier
application applno (NDA): 205582
application number: NDA205582
ndc (product): 47335-361

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 6 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47335-361decitabinedecitabineSun Pharmaceutical Industries, Inc.NDACurrent
47335-361decitabinedecitabineSun Pharmaceutical Industries, Inc.NDACurrent
47335-361decitabinedecitabineSun Pharmaceutical Industries, Inc.NDACurrent
47335-361decitabinedecitabineSun Pharmaceutical Industries, Inc.NDACurrent
47335-361decitabinedecitabineSun Pharmaceutical Industries, Inc.NDACurrent
47335-361decitabinedecitabineSun Pharmaceutical Industries, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64619SUPPL2020-09-21
64591SUPPL2020-09-17
63314SUPPL2020-05-28
63262SUPPL2020-05-22
61778SUPPL2020-02-05
61773SUPPL2020-02-04
58843SUPPL2019-05-23
58839SUPPL2019-05-23
44923ORIG2014-06-27
22994ORIG2014-06-27
19660ORIG2014-01-28
10469ORIG2014-01-24